NCT05200598View on ClinicalTrials.gov

Cardiovascular Risk Predictors in Patients With Psoriasis

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

September 1, 2023

Study Completion Date

September 1, 2024

Conditions
PsoriasisCardiovascular Diseases
Trial Locations (1)

119991

University Clinical Hospital #2, Moscow

All Listed Sponsors
lead

I.M. Sechenov First Moscow State Medical University

OTHER

NCT05200598 - Cardiovascular Risk Predictors in Patients With Psoriasis | Biotech Hunter | Biotech Hunter